Brickell’s losses mount as firm struggles with Nasdaq listing
BOULDER — Brickell Biotech Inc. (Nasdaq: BBI), a clinical-stage pharmaceutical company that’s developing a gel to treat excessive sweating, grew […]
Source: BizWest
Related Articles
BizWest celebrates 40 years covering business and recognizes 40 iconic leaders who inspired the region’s development.
View related stories: Click here to view the 40th Anniversary supplement. ‘Turnpike’ helps define how economy has changed Wood: Preserving…
Brickell Biotech launches brand reset amid positioning pivot
BOULDER — Brickell Biotech Inc. (Nasdaq: BBI), a clinical-stage pharmaceutical company, has launched a new brand, logo and website as…
Biotechnology boom
The COVID-19 pandemic — and its seemingly never-ending aftermath — has been a nightmare for commercial landlords of many different…
Fresh Tracks Therapeutics informs investors of Silicon Valley Bank account
BOULDER — Fresh Tracks Therapeutics Inc. (Nasdaq: FRTX) holds an account with the failed Silicon Valley Bank, the Boulder-based pharmaceutical…
Fresh Tracks Therapeutics improves revenue, decreases loss during ‘transformational’ quarter
BOULDER — Fresh Tracks Therapeutics Inc. (Nasdaq: FRTX), the Boulder-based pharmaceutical company formerly called Brickell Biotech, saw both its top…